South Korea
# |
Name |
Total Assets |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 15.30 B
|
Dec. 31, 2023 | USD 119.86 | -2.20% |
|
South Korea |
|
2 |
USD 12.32 B
|
Dec. 31, 2023 | USD 745.69 | 1.15% |
|
South Korea |
|
3 |
USD 2.91 B
|
Dec. 31, 2023 | USD 8.02 | 4.65% |
|
South Korea |
|
4 |
USD 2.87 B
|
Dec. 31, 2023 | USD 9.61 | -3.70% |
|
South Korea |
|
5 |
USD 2.03 B
|
Dec. 31, 2023 | USD 88.80 | -5.65% |
|
South Korea |
|
6 |
USD 1.85 B
|
Dec. 31, 2023 | USD 83.97 | -5.00% |
|
South Korea |
|
7 |
USD 1.81 B
|
Dec. 31, 2023 | USD 13.69 | -2.57% |
|
South Korea |
|
8 |
USD 1.50 B
|
Dec. 31, 2023 | USD 65.38 | -0.04% |
|
South Korea |
|
9 |
USD 1.46 B
|
Dec. 31, 2023 | USD 159.35 | -4.24% |
|
South Korea |
|
10 |
USD 1.42 B
|
Dec. 31, 2023 | USD 32.21 | -3.61% |
|
South Korea |
|
11 |
USD 1.36 B
|
Dec. 31, 2023 | USD 89.76 | -4.42% |
|
South Korea |
|
12 |
USD 1.12 B
|
Dec. 31, 2023 | USD 31.05 | -1.12% |
|
South Korea |
|
13 |
USD 1.08 B
|
Dec. 31, 2023 | USD 56.39 | -4.53% |
|
South Korea |
|
14 |
USD 1.06 B
|
Dec. 31, 2023 | USD 5.23 | -2.06% |
|
South Korea |
|
15 |
USD 1.01 B
|
Dec. 31, 2023 | USD 23.36 | -2.28% |
|
South Korea |
|
16 |
USD 971.08 M
|
Dec. 31, 2023 | USD 33.57 | -2.13% |
|
South Korea |
|
17 |
USD 961.12 M
|
Dec. 31, 2023 | USD 15.77 | -2.26% |
|
South Korea |
|
18 |
USD 941.70 M
|
Dec. 31, 2023 | USD 18.22 | -3.57% |
|
South Korea |
|
19 |
USD 827.95 M
|
Dec. 31, 2023 | USD 3.69 | -1.06% |
|
South Korea |
|
20 |
USD 703.11 M
|
Dec. 31, 2023 | USD 6.82 | -1.91% |
|
South Korea |
|
21 |
USD 644.76 M
|
Dec. 31, 2023 | USD 9.85 | -4.50% |
|
South Korea |
|
22 |
USD 606.98 M
|
Dec. 31, 2023 | USD 7.87 | -2.10% |
|
South Korea |
|
23 |
USD 555.40 M
|
Dec. 31, 2023 | USD 70.28 | -5.55% |
|
South Korea |
|
24 |
USD 518.73 M
|
Dec. 31, 2023 | USD 54.68 | -7.62% |
|
South Korea |
|
25 |
USD 495.39 M
|
Dec. 31, 2023 | USD 15.49 | -2.92% |
|
South Korea |
|
26 |
USD 492.78 M
|
Dec. 31, 2023 | USD 34.59 | -4.65% |
|
South Korea |
|
27 |
USD 469.73 M
|
Dec. 31, 2023 | USD 77.77 | -3.69% |
|
South Korea |
|
28 |
USD 452.66 M
|
Dec. 31, 2023 | USD 0.50 | -4.09% |
|
South Korea |
|
29 |
USD 450.74 M
|
Dec. 31, 2023 | USD 12.66 | -2.66% |
|
South Korea |
|
30 |
USD 433.90 M
|
Dec. 31, 2023 | USD 4.07 | -1.95% |
|
South Korea |
|
31 |
USD 390.14 M
|
Dec. 31, 2023 | USD 9.80 | -1.72% |
|
South Korea |
|
32 |
USD 383.83 M
|
Dec. 31, 2023 | USD 8.44 | -2.89% |
|
South Korea |
|
33 |
USD 329.49 M
|
Dec. 31, 2023 | USD 3.10 | -3.13% |
|
South Korea |
|
34 |
USD 325.25 M
|
Dec. 31, 2023 | USD 7.21 | -0.62% |
|
South Korea |
|
35 |
USD 322.48 M
|
Dec. 31, 2023 | USD 11.62 | -0.90% |
|
South Korea |
|
36 |
USD 321.94 M
|
Dec. 31, 2023 | USD 10.66 | -1.34% |
|
South Korea |
|
37 |
USD 308.14 M
|
Dec. 31, 2023 | USD 7.90 | -1.67% |
|
South Korea |
|
38 |
USD 289.22 M
|
Dec. 31, 2023 | USD 3.04 | -3.81% |
|
South Korea |
|
39 |
USD 284.68 M
|
Dec. 31, 2023 | USD 8.58 | -5.12% |
|
South Korea |
|
40 |
USD 282.34 M
|
Dec. 31, 2023 | USD 11.86 | -0.20% |
|
South Korea |
|
41 |
USD 273.92 M
|
Dec. 31, 2023 | USD 7.33 | -4.07% |
|
South Korea |
|
42 |
USD 268.86 M
|
Dec. 31, 2023 | USD 6.88 | -1.99% |
|
South Korea |
|
43 |
USD 257.98 M
|
Dec. 31, 2023 | USD 2.87 | -2.35% |
|
South Korea |
|
44 |
USD 242.29 M
|
Dec. 31, 2023 | USD 11.53 | -7.22% |
|
South Korea |
|
45 |
USD 225.63 M
|
Dec. 31, 2023 | USD 14.37 | -3.79% |
|
South Korea |
|
46 |
USD 210.78 M
|
Dec. 31, 2023 | USD 16.51 | 0.47% |
|
South Korea |
|
47 |
USD 201.39 M
|
Dec. 31, 2023 | USD 15.36 | -2.10% |
|
South Korea |
|
48 |
USD 196.68 M
|
Dec. 31, 2023 | USD 240.05 | -5.25% |
|
South Korea |
|
49 |
USD 187.57 M
|
Dec. 31, 2023 | USD 4.14 | -7.03% |
|
South Korea |
|
50 |
USD 186.71 M
|
Dec. 31, 2023 | USD 1.61 | -1.19% |
|
South Korea |
The Healthcare company in South Korea with the highest Total Assets is Celltrion, Inc. (KSE: 068270.KS) at USD 15.30 B.
The Healthcare company in South Korea with the lowest Total Assets is Gencurix Inc. (KOSDAQ: 229000.KQ) at USD 25.73 M.
The top 10 Healthcare companies in South Korea by Total Assets are Celltrion, Inc., Samsung Biologics Co.,Ltd., SD BioSensor, Inc, Green Cross Holdings Corporation, Green Cross Corporation, Yuhan Corporation, Daewoong Co., Ltd., Dong-A Socio Holdings Co., Ltd., Hanmi Pharm. Co., Ltd. and SK bioscience Co.,Ltd..
The bottom 10 Healthcare companies in South Korea by Total Assets are Gencurix Inc., Peptron, Inc., Hyundai Bioscience Co., Ltd., PCL, Inc., Cellid, Co., Ltd., SillaJen, Inc., MedPacto, Inc., EOFLOW Co.,Ltd., Pharmicell Co., Ltd. and SAMSUNG PHARM. Co., LTD..